According to MediciNova's latest financial reports and stock price the company's current number of shares outstanding is 49,046,246. At the end of 2023 the company had 49,046,246 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 49.04 M | 0% |
2022 | 49.04 M | 0.12% |
2021 | 48.98 M | 9.73% |
2020 | 44.64 M | 3% |
2019 | 43.34 M | 3.5% |
2018 | 41.87 M | 19.12% |
2017 | 35.15 M | 1.97% |
2016 | 34.47 M | 28.01% |
2015 | 26.93 M | 11.52% |
2014 | 24.14 M | 8.29% |
2013 | 22.3 M | 34.47% |
2012 | 16.58 M | 8.21% |
2011 | 15.32 M | 23.08% |
2010 | 12.45 M | 2.76% |
2009 | 12.11 M | 0.39% |
2008 | 12.07 M | 2.58% |
2007 | 11.76 M | 15.22% |
2006 | 10.21 M | 3.32% |
2005 | 9.88 M | 1877.12% |
2004 | 0.5 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Novartis NVS | 2,044,000,000 | 4,067.50% | ๐จ๐ญ Switzerland |
Eli Lilly LLY | 949,379,000 | 1,835.68% | ๐บ๐ธ USA |
Sanofi SNY | 2,507,200,000 | 5,011.91% | ๐ซ๐ท France |
Titan Pharmaceuticals
TTNP | 750,800 | -98.47% | ๐บ๐ธ USA |
Alkermes ALKS | 166,607,000 | 239.69% | ๐ฎ๐ช Ireland |
Teva Pharmaceutical Industries TEVA | 1,121,000,000 | 2,185.60% | ๐ฎ๐ฑ Israel |